Voyager Therapeutics, Inc. (CIK: 0001640266) EDGAR, Information, Filings... CompaniesBIO.Com

Voyager Therapeutics, Inc.

Mailing address
64 SIDNEY STREET, CAMBRIDGE, Delaware, 02139
Phone
857-259-5340
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Voyager Therapeutics, Inc. (CIK: 0001640266) is an American company incorporated in the state of Massachusetts. Head office is located at 64 SIDNEY STREET, CAMBRIDGE, Massachusetts, 02139. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Voyager Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Fahey Sandell Jacquelyn	0001984647	Jul-10-2023	officer: Chief Legal Officer
SCANGOS GEORGE A	0001202102	May-09-2023	director
NEUROCRINE BIOSCIENCES INC	0000914475	Feb-23-2023	10 percent owner
Onyia Jude	0001894425	Feb-23-2023	director
Colon Grace	0001780354	Jan-01-2023	director
PFREUNDSCHUH PETER P.	0001585839	Sep-19-2022	officer: Chief Financial Officer
Carter Todd Alfred	0001944011	Sep-19-2022	officer: Chief Scientific Officer
MACKEY CATHERINE J	0001645330	Aug-15-2022	director
EcoR1 Capital, LLC	0001587114	Apr-21-2022	10 percent owner
Sandrock Alfred	0001577061	Feb-07-2022	director
Swartz Robin	0001909636	Feb-07-2022	officer: Chief Operating Officer
Burek Julie	0001894915	Nov-26-2021	officer: Vice President, Finance
Vitale Nancy	0001823262	Sep-15-2020	director
Khwaja Omar	0001776393	May-20-2019	officer: See Remarks
Hesslein Robert W.	0001585018	Apr-01-2019	officer: Senior VP & General Counsel
Turenne Andre	0001747102	Jul-16-2018	director, officer: President & CEO
Dorval Allison	0001625110	Jun-08-2018	officer: Vice President, Finance
Ottmer Matthew P.	0001659870	Sep-14-2017	officer: Chief Operating Officer
Sah Dinah Ph.D.	0001711043	Jun-29-2017	officer: Chief Scientific Officer
Ravina Bernard	0001711276	Jun-29-2017	officer: Chief Medical Officer
DIXON WENDY L	0001202283	Jan-01-2017	director
PIERCE GLENN	0001256964	Jan-01-2017	director
Henderson Jane	0001422304	Jan-01-2017	officer: Sr. V.P. & CFO
LEVIN MARK J	0001180428	Dec-19-2016	director, 10 percent owner
TEPPER ROBERT I	0001192595	Dec-19-2016	10 percent owner
STARR KEVIN P	0001192603	Dec-19-2016	10 percent owner
Third Rock Ventures III, L.P.	0001569705	Dec-19-2016	10 percent owner
TRV GP III, LLC	0001637299	Dec-19-2016	10 percent owner
Third Rock Ventures GP III, L.P.	0001637300	Dec-19-2016	10 percent owner
Sanofi	0001121404	Nov-10-2015	10 percent owner
PAUL STEVEN M	0001237564	Nov-10-2015	director, officer: President and CEO
GERAGHTY JAMES A	0001239746	Nov-10-2015	director
KARSEN PERRY A	0001260573	Nov-10-2015	director
Higgins Michael J	0001478521	Nov-10-2015	director
Hadley Harbor Master Investors (Cayman) L.P.	0001641080	Nov-10-2015	10 percent owner
Goater Jeff	0001656435	Nov-10-2015	officer: SVP Finance, Bus. Development
Hyman Steven	0001656506	Nov-10-2015	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Voyager Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001086364-24-008406 (34 Act) Size: 13 KB	Aug-07-2024	005-89173 241183774
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001104659-24-086270 (33 Act) Size: 142 KB	Aug-06-2024	333-281285 241179339
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001558370-24-011073 (34 Act) Size: 6727 KB	Aug-06-2024	001-37625 241178978
8-K	Document	Current report filing Acc-no: 0001558370-24-011071 (34 Act) Size: 345 KB	Aug-06-2024	001-37625 241178924
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-078547 ( Act) Size: 6 KB	Jul-09-2024
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001104659-24-078546 ( Act) Size: 11 KB	Jul-09-2024
8-K	Document	Current report filing Acc-no: 0001104659-24-071048 (34 Act) Size: 309 KB	Jun-13-2024	001-37625 241040000
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069667 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069666 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069665 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069664 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069662 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069659 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069658 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069656 ( Act) Size: 5 KB	Jun-07-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-069650 ( Act) Size: 5 KB	Jun-07-2024
8-K	Document	Current report filing Acc-no: 0001104659-24-069063 (34 Act) Size: 204 KB	Jun-06-2024	001-37625 241024987
8-K	Document	Current report filing Acc-no: 0001104659-24-062257 (34 Act) Size: 192 KB	May-16-2024	001-37625 24953546
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001558370-24-007953 (34 Act) Size: 6347 KB	May-13-2024	001-37625 24938872
8-K	Document	Current report filing Acc-no: 0001558370-24-007951 (34 Act) Size: 295 KB	May-13-2024	001-37625 24938822

Recent 20 filings. View all Voyager Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Voyager Therapeutics, Inc. overview
Voyager Therapeutics, Inc. job
Voyager Therapeutics, Inc. stock
Voyager Therapeutics, Inc. ownership
Voyager Therapeutics, Inc. CEO
Voyager Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.